test-upload-widen-2.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2051 - 2060 ntawm 4179
Tus kws kho mob
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
QP43-24 MHCP Pharmacy Benefit Exclusion for Alyglo™ and Lenmeldy™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
QP42-24 Commercial Pharmacy Benefit Exclusion for Lenmeldy™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
QP41-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
QP39-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
QP40-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2024
Tus kws kho mob
2024 May Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P34-24 Updated Reimbursement Policies, Effective July 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2024